Immune Issues After Adjuvant Anti–PD-1 Therapy in Melanoma ...Middle East

Medscape - News
Chronic immune-related adverse events often persist years after adjuvant anti–PD-1 immunotherapy for high-risk melanoma and may require prolonged monitoring and management, researchers say. Medscape Medical News

Hence then, the article about immune issues after adjuvant anti pd 1 therapy in melanoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immune Issues After Adjuvant Anti–PD-1 Therapy in Melanoma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News